3.7CVJun 14, 2022
Asymmetric Dual-Decoder U-Net for Joint Rain and Haze RemovalYuan Feng, Yaojun Hu, Pengfei Fang et al.
This work studies the joint rain and haze removal problem. In real-life scenarios, rain and haze, two often co-occurring common weather phenomena, can greatly degrade the clarity and quality of the scene images, leading to a performance drop in the visual applications, such as autonomous driving. However, jointly removing the rain and haze in scene images is ill-posed and challenging, where the existence of haze and rain and the change of atmosphere light, can both degrade the scene information. Current methods focus on the contamination removal part, thus ignoring the restoration of the scene information affected by the change of atmospheric light. We propose a novel deep neural network, named Asymmetric Dual-decoder U-Net (ADU-Net), to address the aforementioned challenge. The ADU-Net produces both the contamination residual and the scene residual to efficiently remove the rain and haze while preserving the fidelity of the scene information. Extensive experiments show our work outperforms the existing state-of-the-art methods by a considerable margin in both synthetic data and real-world data benchmarks, including RainCityscapes, BID Rain, and SPA-Data. For instance, we improve the state-of-the-art PSNR value by 2.26/4.57 on the RainCityscapes/SPA-Data, respectively. Codes will be made available freely to the research community.
Personalized Heart Disease Detection via ECG Digital Twin GenerationYaojun Hu, Jintai Chen, Lianting Hu et al.
Heart diseases rank among the leading causes of global mortality, demonstrating a crucial need for early diagnosis and intervention. Most traditional electrocardiogram (ECG) based automated diagnosis methods are trained at population level, neglecting the customization of personalized ECGs to enhance individual healthcare management. A potential solution to address this limitation is to employ digital twins to simulate symptoms of diseases in real patients. In this paper, we present an innovative prospective learning approach for personalized heart disease detection, which generates digital twins of healthy individuals' anomalous ECGs and enhances the model sensitivity to the personalized symptoms. In our approach, a vector quantized feature separator is proposed to locate and isolate the disease symptom and normal segments in ECG signals with ECG report guidance. Thus, the ECG digital twins can simulate specific heart diseases used to train a personalized heart disease detection model. Experiments demonstrate that our approach not only excels in generating high-fidelity ECG signals but also improves personalized heart disease detection. Moreover, our approach ensures robust privacy protection, safeguarding patient data in model development.
TrialBench: Multi-Modal Artificial Intelligence-Ready Clinical Trial DatasetsJintai Chen, Yaojun Hu, Mingchen Cai et al.
Clinical trials are pivotal for developing new medical treatments but typically carry risks such as patient mortality and enrollment failure that waste immense efforts spanning over a decade. Applying artificial intelligence (AI) to predict key events in clinical trials holds great potential for providing insights to guide trial designs. However, complex data collection and question definition requiring medical expertise have hindered the involvement of AI thus far. This paper tackles these challenges by presenting a comprehensive suite of 23 meticulously curated AI-ready datasets covering multi-modal input features and 8 crucial prediction challenges in clinical trial design, encompassing prediction of trial duration, patient dropout rate, serious adverse event, mortality rate, trial approval outcome, trial failure reason, drug dose finding, design of eligibility criteria. Furthermore, we provide basic validation methods for each task to ensure the datasets' usability and reliability. We anticipate that the availability of such open-access datasets will catalyze the development of advanced AI approaches for clinical trial design, ultimately advancing clinical trial research and accelerating medical solution development.